Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy

Phytochemistry

Volumn 62, Issue 1, 2003, Pages 89-99

  Vaya, Jacob ^a   Mahmood, Saeed ^a   Goldblum, Amiram ^b   Aviram, Michael ^c   Volkova, Nina ^c   Shaalan, Amin ^a   Musa, Ramadan ^a   Tamir, Snait ^a  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Flavonoids; Free radical; Heat of formation; LDL; Oxidation

Indexed keywords

2' HYDROXYFLAVANONE; 4' HYDROXYFLAVANONE; 7 HYDROXYFLAVONE; 7,3',4' TRIHYDROXYFLAVONE; APIGENIN; BIOCHANIN A; CATECHIN; CHRYSIN; DAIDZEIN; FLAVANONE DERIVATIVE; FLAVONOID; FREE RADICAL; GALANIN; GENISTEIN; HESPERETIN; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; LUTEOLIN; MYRICETIN; NARINGENIN; PRIMULETIN; QUERCETIN; TAXIFOLIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENTHALPY; HUMAN; LIPID OXIDATION; NORMAL HUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

AMIDINES; ANTIOXIDANTS; CHOLESTEROL, LDL; COPPER; FLAVONOIDS; FREE RADICALS; HUMANS; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PICRATES; STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS;

EID: 0038600760     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9422(02)00445-4     Document Type: Article

References (35)

1. Aviram, M., 1983. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30, 111-118.
2. Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., Fuhrman, B., 2000. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 71, 1062-1076.
3. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C.L., Newton, R.S., La Du, B., 1999. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26, 892-904.
4. Belinky, P.A., Aviram, M., Fuhrman, B., Rosenblat, M., Vaya, J., 1998a. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137, 49-61.
5. Belinky, P.A., Aviram, M., Mahmood, S., Vaya, J., 1998b. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic. Biol. Med. 24, 1419-1429.
6. Bors, W., Heller, W., Michel, C., Saran, M., 1990. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 186, 343-355.
7. Brown, J.E., Khodr, H., Hider, R.C., Rice-Evans, C.A., 1998. Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochem. J. 330, 1173-1178.
8. Buege, J.A., Aust, S.D., 1978. Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310.
9. Burda, S., Oleszek, W., 2001. Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem. 49, 2774-2779.
10. Cao, G., Sofic, E., Prior, R.L., 1997. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22, 749-760.
11. Croft, K.D., 1998. The chemistry and biological effects of flavonoids and phenolic acids. Ann. NY Acad. Sci. 854, 435-442.
12. Di Carlo, G., Mascolo, N., Izzo, A.A., Capasso, F., 1999. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 65, 337-353.
13. Esterbauer, H., 1995. The chemistry of oxidation of lipoproteins. In: Rice-Evans, C., Bruckdorfer, K.R. (Eds.), Oxidative Stress, Lipoproteins and Cardiovascular Dysfunction. Portland Press, London, pp. 55-79.
14. Esterbauer, H., Puhl, H., Waeg, G., Krebs, A., Tatzber, F., Rabl, H., 1992. Vitamin E and atherosclerosis: an overview. J. Nutr. Sci. Vitaminol. (Tokyo) Spec 177-182.
15. Esterbauer, H., Striegl, G., Puhl, H., Rotheneder, M., 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6, 67-75.
16. Frei, B., Gaziano, J.M., 1993. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and-independent oxidation. J. Lipid. Res. 34, 2135-2145.
17. Fuhrman, B., Buch, S., Vaya, J., Belinky, P.A., Coleman, R., Hayek, T., Aviram, M., 1997. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 66, 267-275.
18. Fuhrman, B., Rosenblat, M., Hayek, T., Coleman, R., Aviram, M., 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr. 130, 1124-1131.
19. Heijnen, C.G., Haenen, G.R., van Acker, F.A., van der Vijgh, W.J., Bast, A., 2001. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol. In Vitro 15, 3-6.
20. Heinecke, J.W., 1997. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8, 268-274.
21. Jovanovic, S.V., Steenken, S., Tosic, M., Marjanovic, B., Simic, M.G., 1994. Flavonoids as anti-oxidants. J. Am. Chem. Soc. 116, 4846-4852.
22. Lien, E.J., Ren, S., Bui, H.H., Wang, R., 1999. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic. Biol. Med. 26, 285-294.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Morel, I., Lescoat, G., Cogrel, P., Sergent, O., Pasdeloup, N., Brissot, P., Cillard, P., Cillard, J., 1993. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13-19.
25. Ng, T.B., Liu, F., Wang, Z.T., 2000. Antioxidative activity of natural products from plants. Life Sci. 66, 709-723.
26. Phelps, S., Harris, W.S., 1993. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 28, 475-477.
27. Renaud, S., de Lorgeril, M., 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease [see comments]. Lancet 339, 1523-1526.
28. Rice-Evans, C.A., Miller, N.J., Paganga, G., 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids [published erratum appears in Free Radic Biol Med 1996;21(3):417]. Free Radic. Biol. Med. 20, 933-956.
29. Ruiz-Larrea, M.B., Mohan, A.R., Paganga, G., Miller, N.J., Bolwell, G.P., Rice-Evans, C.A., 1997. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 26, 63-70.
30. Stewart, J.P., 198. Optimization of parameters for semi-empirical methods-method. J. Comp. Chem, 10, 210-220.
31. van Acker, S.A., de Groot, M.J., van den Berg, D.J., Tromp, M.N., Donne-Op den Kelder, G., van der Vijgh, W.J., Bast, A., 1996a. A quantum chemical explanation of the antioxidant activity of flavonoids. Chem. Res. Toxicol. 9, 1305-1312.
32. van Acker, S.A., van den Berg, D.J., Tromp, M.N., Griffioen, D.H., van Bennekom, W.P., van der Vijgh, W.J., Bast, A., 1996b. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20, 331-342.
33. van het Hof, K.H., de Boer, H.S., Wiseman, S.A., Lien, N., Westrate, J.A., Tijburg, L.B., 1997. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 66, 1125-1132.
34. Vaya, J., Belinky, P.A., Aviram, M., 1997. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic. Biol. Med. 23, 302-313.
35. Visioli, F., Galli, C., 1995. Natural anti-oxidants and prevention of coronary heart disease: a potential role of olive oil and its minor constituents. Nutr. Metab. Cardiovasc. Dis. 5, 306-314.